No New Meds

With drug firms in retreat, the pipeline for new psychiatric medications dries up

Michael Morgenstern

Psychiatry seemed poised on the edge of a breakthrough. In early 2011, after decades of no radically new drugs, a fundamentally different schizophrenia treatment promised relief from the psychotic hallucinations and delusions plaguing people with the disease.